A nurse is caring for a child who has pertussis. The child's parent asks the nurse what the common name for this disease is. The nurse should
respond with which of the following common names?

Choice A reason: This is not a correct description of Bryant traction. This type of traction does not involve pins or wires inserted into the bone. It is a skin traction that uses adhesive straps or bandages attached to the skin of the lower legs.

Choice B reason: This is not a correct description of Bryant traction. This type of traction does not maintain the leg in an extended position. It flexes the hip and knee at a 90-degree angle and suspends the leg in the air.

Choice C reason: This is not a correct description of Bryant traction. This type of traction does not use a sling under the knee of the affected leg. It uses a spreader bar to keep the legs apart and prevent rotation.

Choice D reason: This is a correct description of Bryant traction. This type of traction elevates the buttocks slightly off of the bed to provide countertraction and alignment of the fractured bone.

Choice A reason: A 2-year-old toddler is not a recommended recipient of the MCV4 vaccine, as it is not routinely given to children younger than 11 years old, unless they have certain medical conditions that increase their risk of meningococcal disease, such as asplenia, complement deficiency, or HIV infection. A 2-year-old toddler may receive the meningococcal polysaccharide (MPSV4) vaccine instead, if indicated.

Choice B reason: A 4-month-old infant is not a recommended recipient of the MCV4 vaccine, as it is not routinely given to children younger than 11 years old, unless they have certain medical conditions that increase their risk of meningococcal disease, such as asplenia, complement deficiency, or HIV infection. A 4-month-old infant may receive the meningococcal serogroup B (MenB) vaccine instead, if indicated.

Choice C reason: An 11-year-old school-age child is a recommended recipient of the MCV4 vaccine, as it is routinely given to children aged 11 to 12 years old, with a booster dose at age 16. The MCV4 vaccine protects against four types of meningococcal bacteria (A, C, W, and Y) that can cause serious infections of the lining of the brain and spinal cord (meningitis) or the bloodstream (septicemia).

Choice D reason: A 4-year-old child is not a recommended recipient of the MCV4 vaccine, as it is not routinely given to children younger than 11 years old, unless they have certain medical conditions that increase their risk of meningococcal disease, such as asplenia, complement deficiency, or HIV infection. A 4-year-old child may receive the meningococcal polysaccharide (MPSV4) vaccine instead, if indicated.